Ebola virus-like particles protect from lethal Ebola virus infection. - Test2 - elhamkhani - TriplyDB

Ebola virus-like particles protect from lethal Ebola virus infection.

Ebola virus-like particles protect from lethal Ebola virus infection.

http://www.wikidata.org/entity/Q34792924

about

Animal models for Ebola and Marburg virus infections Current ebola vaccines Antigenic protein modifications in Ehrlichia Gene-specific countermeasures against Ebola virus based on antisense phosphorodiamidate morpholino oligomers.The Role of Cytokines and Chemokines in Filovirus Infection Ebola virus vaccines: an overview of current approaches Particulate delivery systems for vaccination against bioterrorism agents and emerging infectious pathogens Mouse models for filovirus infections Vaccine To Confer to Nonhuman Primates Complete Protection against Multistrain Ebola and Marburg Virus Infections Neutralizing ebolavirus: structural insights into the envelope glycoprotein and antibodies targeted against it Ebola and Marburg virus vaccines.Virus like particle-based vaccines against emerging infectious disease viruses.Toll-like receptor agonist augments virus-like particle-mediated protection from Ebola virus with transient immune activation.Molecular determinants of Ebola virus virulence in mice.Interaction between Ebola virus glycoprotein and host toll-like receptor 4 leads to induction of proinflammatory cytokines and SOCS1.A replication-incompetent Rift Valley fever vaccine: chimeric virus-like particles protect mice and rats against lethal challenge Contribution of virus-like particles to the immunogenicity of human immunodeficiency virus type 1 Gag-derived vaccines in mice Comprehensive analysis of ebola virus GP1 in viral entry.Ebola virus glycoprotein directly triggers T lymphocyte death despite of the lack of infection.Protection of nonhuman primates against two species of Ebola virus infection with a single complex adenovirus vector.Role of Ebola virus secreted glycoproteins and virus-like particles in activation of human macrophages Subviral particle as vaccine and vaccine platform.Relevant uses of surface proteins--display on self-organized biological structures.Consequences of non-intervention for infectious disease in African great apes.Protective cytotoxic T-cell responses induced by venezuelan equine encephalitis virus replicons expressing Ebola virus proteins A "Trojan horse" bispecific-antibody strategy for broad protection against ebolaviruses Ebolavirus Glycoprotein Fc Fusion Protein Protects Guinea Pigs against Lethal Challenge.Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge.Vesicular stomatitis virus-based Ebola vaccines with improved cross-protective efficacy.Ebola virus glycoprotein Fc fusion protein confers protection against lethal challenge in vaccinated mice.Mechanisms of immunity in post-exposure vaccination against Ebola virus infection.Functional genomics reveals the induction of inflammatory response and metalloproteinase gene expression during lethal Ebola virus infection.Homologous and heterologous protection of nonhuman primates by Ebola and Sudan virus-like particles.Inactivated or live-attenuated bivalent vaccines that confer protection against rabies and Ebola viruses.Impact of Ebola mucin-like domain on antiglycoprotein antibody responses induced by Ebola virus-like particles.Advances in virus-like particle vaccines for filoviruses.Filovirus vaccines.Hegemonic structure of basic, clinical and patented knowledge on Ebola research: a US army reductionist initiative.Induction of ebolavirus cross-species immunity using retrovirus-like particles bearing the Ebola virus glycoprotein lacking the mucin-like domain.The role of antigen-presenting cells in filoviral hemorrhagic fever: gaps in current knowledge.

P2860

Q21131118-5135516C-2653-4512-BA41-A01C3761B11D Q21534720-F074CD6C-0104-4DCD-B88C-C5034E313CAF Q24647291-D74AA754-C006-4FE6-B4E2-8022321BF252 Q25256700-A4350BD7-60A1-4FEA-BCFE-B249E8427468 Q26778003-2CB714EE-ED90-4ADF-ADAA-2D62B5674F96 Q26999232-61D43BEC-8BBB-448B-ACAE-C5E410F09AAA Q27011190-4D5563B4-61A4-4777-A1E1-583037F844B9 Q27011569-89962B5C-72F1-4CBA-8210-A249E979C944 Q27485491-A1008563-F976-4699-931A-FFCEEED9F327 Q27489891-8E20F1D5-7805-4E05-80C1-E944B0D98761 Q30234637-9F69CFD0-86D2-4E70-BD7E-ED701FE8CD13 Q30249025-556F1B89-3D1A-490F-B1E8-68FEE2B78C81 Q31152190-3F6C4A5A-663D-48A6-B2BA-1E8ED9831C4E Q33250567-16354BA5-C6E7-4101-A1A7-14ED978245F0 Q33558670-101115BC-1245-4E83-88A0-D7DDCB8A5B38 Q33621078-89526E63-DD3C-4481-8D04-96580712C17A Q33717736-11EC7A95-0313-4C9E-83AE-784135ED81DD Q33724185-5D429269-B393-43F3-9A0D-2CF72ADC8E98 Q33758034-19CFA448-9A0C-4DB6-B51F-C644DF2A17E1 Q33768646-F457911E-17EF-40CB-B533-650C5C9DF61E Q33781224-7C1A31D2-9320-4886-83DC-64B0E337C437 Q33812653-E13E87CA-BB00-4288-BD11-1A38CD981F0E Q34015207-E0E01004-B806-4739-BCEF-3524CCA615DA Q34117137-5C03AAFD-0E01-4DFD-A7F1-587013BB5C1C Q34123838-D39F5962-BA0E-404E-9AB0-E53104EA4AF9 Q34539842-E9A71DCD-1238-4DCA-AE24-5DCAA5BB5556 Q34540207-F8604DF5-5247-4BD5-88EF-4FF7202A6233 Q34583832-956A2393-7320-43AA-BE3A-4E13CE4AFEAA Q34632946-62EA3B35-378B-4C5F-94DE-86A4C2EB4688 Q34761889-066C5501-0EF7-40F7-878C-5D80EDB9251D Q35192417-B40A1C4E-C8EB-4849-892C-1A2D1A0AFA53 Q35193052-DA0A437E-5820-43F0-9BC4-0235AC067782 Q35202880-18753C84-4B00-4372-A458-9D06DA5B12C8 Q35275167-5BC713ED-AAEE-4EAC-B14E-F46A63A50AEC Q35299756-856C038F-8417-4AD6-B926-A6CE64B045FF Q35300029-D7047DA1-7F02-4991-9C7A-685B2A4572DC Q35558539-C0BDEC48-CE0F-4B96-AB8E-64C9DBDE165D Q35595035-D1B7E1A0-CBF7-4E49-A28D-4631A705E763 Q35772032-410FEEA6-1E4F-42E3-8EF2-BC5628C5EB71 Q35823426-5AC36CF8-7E03-459C-81B3-1BD494488567

P2860

Ebola virus-like particles protect from lethal Ebola virus infection.

http://www.wikidata.org/entity/Q34792924

description

2003 nî lūn-bûn

@nan

2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Ebola virus-like particles protect from lethal Ebola virus infection.

@ast

Ebola virus-like particles protect from lethal Ebola virus infection.

@en

Ebola virus-like particles protect from lethal Ebola virus infection.

@nl

type

label

Ebola virus-like particles protect from lethal Ebola virus infection.

@ast

Ebola virus-like particles protect from lethal Ebola virus infection.

@en

Ebola virus-like particles protect from lethal Ebola virus infection.

@nl

prefLabel

Ebola virus-like particles protect from lethal Ebola virus infection.

@ast

Ebola virus-like particles protect from lethal Ebola virus infection.

@en

Ebola virus-like particles protect from lethal Ebola virus infection.

@nl

P1433

Q34792924-25F6F808-8A07-4B37-AF7F-DAF9D4E0F37F

P1476

Q34792924-1ADF3EA3-69CA-43FB-AC2B-62A011B45DBD

P2093

Q34792924-099AFB32-372C-453E-BC27-33DB4880289E

Q34792924-4B3DB5F8-5EB0-4948-84B0-B8BF3B152163

Q34792924-7FC4C1D4-6E62-4F82-9AE4-716C62A109A7

Q34792924-81C614FB-FD27-444D-851F-94A93D760A25

Q34792924-A7669A9D-F6BA-4C1F-B55E-A8481A37D8AD

Q34792924-B4AF8E45-7657-4A75-BE92-2783F7FD74EC

Q34792924-DAA3777D-53BA-4838-A0FE-B0886DD096E8

P2860

Q34792924-02C9B094-5010-4266-BFA3-C662479D8E88

Q34792924-04246F9C-0BEC-45B7-BEF2-59F0AFAB7BF6

Q34792924-074805E4-270C-4E0C-94CD-55A5BBB104CE

Q34792924-1939AF8D-ED55-4BCE-BC96-8C7C5043811C

Q34792924-1C0AF4A1-1394-4E44-B0B5-B91E15F3DC68

Q34792924-21876FD1-430E-46BD-BD41-688E9D0D09E2

Q34792924-25F52B41-3777-480D-8542-D1C7F050EA09

Q34792924-263A634E-EDD5-4A1C-BDA0-833684327471

Q34792924-27D3AA65-39D4-4002-9CCF-59B66CA81C62

Q34792924-27FA462E-AA46-4BF5-8924-BA26CE6757F9

P304

Q34792924-C0FE47D6-DD5F-4C69-8B2E-3AC47C5FE871

P31

Q34792924-3E23170F-37C9-401D-89E9-41B764BCA067

P356

Q34792924-19060639-33DD-4367-A53C-34C8399AEF31

P407

Q34792924-20010853-2CB3-490A-B6AD-976945A2D478

P433

Q34792924-E3227A78-3D8A-447C-96AB-B29741D2CA2E

P478

Q34792924-B8A453B8-0A81-4F1A-9CFC-902B980AE57A

P50

Q34792924-45A30BA9-62A0-4EFB-B63E-E0E6423B9B6F

P577

Q34792924-E017F89F-7597-4875-BCCB-D7E18D1DD91F

P5875

Q34792924-E7C2D89A-F865-422E-999F-482CEAB98231

P698

Q34792924-8BBE1C71-E0C0-40C0-AC99-02926987CA64

P921

Q34792924-5ED5743D-1C94-4286-8F45-AF1C21EF038F

P932

Q34792924-339799E2-6D92-4DDB-89D0-AD20B76C9B90

P356

PNAS.2237038100

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Ebola virus-like particles protect from lethal Ebola virus infection.

@en

P2093

Alan Schmaljohn

http://www.w3.org/2001/XMLSchema#string

Brent C Welcher

http://www.w3.org/2001/XMLSchema#string

Catharine M Bosio

http://www.w3.org/2001/XMLSchema#string

Emily M Deal

http://www.w3.org/2001/XMLSchema#string

Kelly L Warfield

http://www.w3.org/2001/XMLSchema#string

M Javad Aman

http://www.w3.org/2001/XMLSchema#string

Mansour Mohamadzadeh

http://www.w3.org/2001/XMLSchema#string

P2860

Antigen presentation and T cell stimulation by dendritic cells

Development of a preventive vaccine for Ebola virus infection in primates

Overcoming immunity to a viral vaccine by DNA priming before vector boosting

Early immune responses accompanying human asymptomatic Ebola infections

Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor

HIV-1 vaccine-induced immune responses which correlate with protection from SHIV infection: compiled preclinical efficacy data from trials with ten different HIV-1 vaccine candidates.

High efficient production of Pr55(gag) virus-like particles expressing multiple HIV-1 epitopes, including a gp120 protein derived from an Ugandan HIV-1 isolate of subtype A.

Parvovirus-like particles as vaccine vectors.

Passive transfer of antibodies protects immunocompetent and imunodeficient mice against lethal Ebola virus infection without complete inhibition of viral replication.

Protection from Ebola virus mediated by cytotoxic T lymphocytes specific for the viral nucleoprotein

P304

15889-15894

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.2237038100

http://www.w3.org/2001/XMLSchema#string

P407

P433

26

http://www.w3.org/2001/XMLSchema#string

P478

100

http://www.w3.org/2001/XMLSchema#string

P50

P577

2003-12-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5656063

http://www.w3.org/2001/XMLSchema#string

P698

14673108

http://www.w3.org/2001/XMLSchema#string

P921

P932

307663

http://www.w3.org/2001/XMLSchema#string